glp 1 gip receptor agonist The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology dual glp 1 and gip
Description
In addition, PKA can also promote Ca 2+ release by activating inositol triphosphate (IP3)
But used wisely, with resistance training, protein optimisation, and patient selection, they may represent the most significant advance in cardiometabolic medicine since statins
GLP-1 contributes to increases in PGC-1 expression by downregulating miR-23a to reduce apoptosis
Patients whose BMI increased had worse outcomes than those with a BMI reduction of 0% to less than 5%
[PMID: 38339186]
E., Lavell, J., and Foreman, R
